Kristine Misund
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 10
- Ubiquitin and proteasome pathways 8
- Glycosylation and Glycoproteins Research 4
- Protein Tyrosine Phosphatases 4
- PI3K/AKT/mTOR signaling in cancer 3
- Hematology 26
- Multiple Myeloma Research and Treatments 25
- Co-authors
- Anders Sundan (23 shared papers)Toril Holien (17 shared papers)Anders Waage (24 shared papers)Torstein B. Rø (7 shared papers)Glenn Buene (8 shared papers)Magne Børset (13 shared papers)Geir Bjørkøy (4 shared papers)Ida Johansson (4 shared papers)
- Journals
- Oncotarget (6 papers)Blood (5 papers)PLoS ONE (3 papers)Blood Cancer Journal (3 papers)Cancer Research (3 papers)
- Partner nations
- NorwayUnited StatesNetherlands
In The Last Decade
Kristine Misund
47 papers receiving 994 citations
Peers
Comparison fields: 5 of 85
- Hematology 268
- Cancer Research 133
- Molecular Biology 624
- Oncology 190
- Immunology 108
Countries citing papers authored by Kristine Misund
This map shows the geographic impact of Kristine Misund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine Misund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine Misund more than expected).
Fields of papers citing papers by Kristine Misund
This network shows the impact of papers produced by Kristine Misund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine Misund. The network helps show where Kristine Misund may publish in the future.
Co-authors
The 25 scholars most cited alongside Kristine Misund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 89 | |
| 2 | 2013 | 82 | |
| 3 | 2018 | 65 | |
| 4 | 2017 | 55 | |
| 5 | 2016 | 49 | |
| 6 | 2018 | 42 | |
| 7 | 2015 | 42 | |
| 8 | 2017 | 41 | |
| 9 | 2014 | 40 | |
| 10 | 2022 | 37 | |
| 11 | 2013 | 35 | |
| 12 | 2016 | 33 | |
| 13 | 2015 | 32 | |
| 14 | 2013 | 31 | |
| 15 | 2016 | 28 | |
| 16 | 2013 | 25 | |
| 17 | 2015 | 24 | |
| 18 | 2020 | 23 | |
| 19 | 2013 | 21 | |
| 20 | 2015 | 21 |
About Kristine Misund
Kristine Misund is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Cancer Research, having authored 50 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (10 papers), Ubiquitin and proteasome pathways (8 papers), Cytokine Signaling Pathways and Interactions (5 papers), Glycosylation and Glycoproteins Research (4 papers), Protein Tyrosine Phosphatases (4 papers), Cancer Mechanisms and Therapy (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Hematology (268 citations), Cancer Research (133 citations), Molecular Biology (624 citations), Oncology (190 citations) and Immunology (108 citations). Kristine Misund has collaborated with scholars based in Norway, United States and Netherlands. Frequent co-authors include Anders Sundan, Toril Holien, Anders Waage, Torstein B. Rø, Glenn Buene, Magne Børset, Geir Bjørkøy, Ida Johansson, Katarzyna Anna Baranowska and Hanne Hella. Their work appears in journals such as Oncotarget, Blood, PLoS ONE, Blood Cancer Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.